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There are three times as many outer hair cells (OHC) as inner hair cells (IHC), yet IHC
transmit virtually all acoustic information to the brain as they synapse with 90–95% of
type I auditory nerve fibers. Here we review a comprehensive series of experiments
aimed at determining how loss of the IHC/type I system affects hearing by selectively
destroying these cells in chinchillas using the ototoxic anti-cancer agent carboplatin.
Eliminating IHC/type I neurons has no effect on distortion product otoacoustic emission
or the cochlear microphonic potential generated by OHC; however, it greatly reduces
the summating potential produced by IHC and the compound action potential (CAP)
generated by type I neurons. Remarkably, responses from remaining auditory nerve fibers
maintain sharp tuning and low thresholds despite innervating regions of the cochlea
with ∼80% IHC loss. Moreover, chinchillas with large IHC lesions have surprisingly
normal thresholds in quiet until IHC losses exceeded 80%, suggesting that only a
few IHC are needed to detect sounds in quiet. However, behavioral thresholds in
broadband noise are elevated significantly and tone-in-narrow band noise masking
patterns exhibit greater remote masking. These results suggest the auditory system
is able to compensate for considerable loss of IHC/type I neurons in quiet but not in
difficult listening conditions. How does the auditory brain deal with the drastic loss of
cochlear input? Recordings from the inferior colliculus found a relatively small decline
in sound-evoked activity despite a large decrease in CAP amplitude after IHC lesion.
Paradoxically, sound-evoked responses are generally larger than normal in the auditory
cortex, indicative of increased central gain. This gain enhancement in the auditory cortex
is associatedwith decreasedGABA-mediated inhibition. These results suggest that when
the neural output of the cochlea is reduced, the central auditory system compensates
by turning up its gain so that weak signals once again become comfortably loud.
While this gain enhancement is able to restore normal hearing under quiet conditions,
it may not adequately compensate for peripheral dysfunction in more complex sound
environments. In addition, excessive gain increases may convert recruitment into the
debilitating condition known as hyperacusis.
Keywords: inner hair cells, carboplatin, central auditory system, auditory gain, auditory cortex, tinnitus,
hyperacusis
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SENSORINEURAL HEARING LOSS AND
THE AUDIOGRAM
The audiogram is often considered the gold standard for
assessing sensorineural hearing loss (HL). Individuals with pure
tone thresholds of ≤20 dB HL would be classified as having
normal hearing. However, there is growing awareness that the
pure tone audiogram fails to detect certain forms of cochlear
pathology and auditory processing deficits. This has led to
the concept of “hidden hearing loss,” i.e., the realization that
significant auditory perceptual deficits can exist in listeners with
normal hearing thresholds, a condition that can exist when there
is considerable IHC and/or auditory nerve fiber degeneration
(Schaette and McAlpine, 2011; Plack et al., 2014; Lobarinas
et al., 2016). Hidden hearing loss is likely involved in some
cases of auditory neuropathy and central auditory processing
disorders, which are characterized by temporal processing
deficits, impaired speech perception, and difficulties hearing in
noisy environments (Kraus et al., 2000; Zeng et al., 2005). It may
also contribute to other auditory perceptual disorders such as
tinnitus and hyperacusis (Schaette and McAlpine, 2011; Hickox
and Liberman, 2014). It is therefore imperative to develop ways
for clinically assessing hidden hearing loss and determining the
consequences of IHC/auditory nerve damage on peripheral and
central auditory processing.
Electrocochleography (ECochG) can be used to interrogate
the functional status of different structures in the cochlea
and identify “hidden” damage to inner hair cells (IHC),
outer hair cells (OHC), the IHC/type I auditory nerve fiber
synapse, and spiral ganglion neurons (SGN). Sensorineural
hearing loss is a complex phenomenon that not only involves
the cochlea, but also numerous structures in the central
auditory system capable of partially compensating for these
cochlear deficits. Therefore, a more complete understanding
of sensorineural hearing loss not only requires assessment
with ECochG, but also examination of the neurophysiological
changes occurring in the central auditory pathway. In this
review, we will discuss our results from a comprehensive
series of electrophysiological, neuroanatomical, behavioral, and
neuropharmacological experiments in a chinchilla animal model
of carboplatin-induced ototoxicity in which there is selective
damage to the IHC and type I auditory nerve fibers that
exclusively innervate the IHC. These studies illustrate how
ECochG can be used to identify damage to the IHC and type
I neurons that goes undetected (i.e., hidden) by the pure tone
audiogram. Electrophysiological recordings from the inferior
colliculus (IC) and auditory cortex (ACx) reveal how weak neural
signals from a damaged cochlea are amplified as they ascend
through the central auditory pathway. Finally, we discuss a few
simple psychophysical tests we have shown can identify hearing
deficits associated with damage to IHC and type I neurons.
CARBOPLATIN-INDUCED IHC AND TYPE I
LESIONS
Cisplatin and other platinum based anti-cancer drugs are
generally more toxic to OHC than IHC, with hair cell lesions
generally progressing from the base toward the apex as the dose
and duration of treatment increases (Boettcher et al., 1992; Rybak
et al., 2007). Carboplatin is a second generation antineoplastic
agent that is considered much less ototoxic than cisplatin
(Ettinger et al., 1994), a view consistent with most studies in
animal models (Saito et al., 1989; Ding et al., 1999). However,
when low-to-moderate doses of carboplatin (50–75mg/kg, i.p.)
were systemically administered to chinchillas, it induced an
unusual lesion that preferentially damaged IHC (Figure 1A), type
I auditory nerve fibers (Figure 1B) and SGN. OHC damage was
only observed at extremely high doses of carboplatin (200mg/kg,
i.p.) (Takeno et al., 1994, 1998; Hofstetter et al., 1997a; Wang
et al., 1997; Ding et al., 1999). Unlike other ototoxic drugs, the
IHC lesion was characterized by a relatively uniform loss of hair
cells along the entire length of the cochlea (Trautwein et al., 1996;
Hofstetter et al., 1997a; Figure 1C). Due to the systemic nature of
treatment, hall cell lesions were similar in both ears (Hofstetter,
1996; Hofstetter et al., 1997a).
To gain insights into the time course of carboplatin-mediated
damage, we counted the number of IHC and nerve fibers in the
habenula perforata 24–72 h after treatment with a moderate dose
of carboplatin (50mg/kg, i.p.) (Wang et al., 2003). Surprisingly,
24 h after carboplatin treatment, only 50% of the nerve fibers in
the habenula perforata were present whereas there was no loss of
IHC (Figure 1D). Significant IHC loss was first observed 3 days
post-carboplatin, but by this time only ∼25% of the nerve fibers
were still present. These results suggest that the auditory nerve
fibers and their afferent synapses are especially susceptible to
carboplatin ototoxicity. To explore this possibility, transmission
electron microscopy was used to examine the morphological
condition of the type I afferent synapse at the base of the IHC. At
24 h post-carboplatin, numerous vacuoles were present around
afferent terminals at the base of the IHC (Figure 1E; Ding et al.,
1997, 1998). Damage to the afferent nerve terminals, IHC and
SGN increased considerably between 24 and 72 h whereas the
morphology of the OHC remained remarkably normal. Vacuoles
were also present on the proximal nerve fibers and transmission
electron microscopy revealed significant loss of myelin around
the nerve fibers 24–72 h post-treatment (Figure 1F; Ding et al.,
2002; Wang et al., 2003). Taken together, these results indicate
that moderate doses of carboplatin can selectively damage IHC
and type I afferent neurons.
MASSIVE IHC LESIONS HAVE LITTLE
EFFECT ON DISTORTION PRODUCT
OTOACOUSTIC EMISSIONS
Distortion product otoacoustic emissions (DPOAE), which
depend on OHC somatic electromotility (Brownell, 1990;
Liberman et al., 2002), provide a noninvasive method for
assessing the functional integrity of the cochlea (Brown et al.,
1989; Schrott et al., 1991; Hofstetter et al., 1997a) and are
widely used to screen for cochlear hearing loss in infants and
adults (Stanton et al., 2005; Jakubíková et al., 2009). Subjects
with normal DPOAE pass the screening test and are generally
believed to have normal hearing; however, since DPOAE are
specifically sensitive to OHC function, this is not always correct,
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FIGURE 1 | (A) Photomicrographs of a surface preparation of the organ of Corti stained with succinate dehydrogenase, a metabolic enzyme highly expressed in OHC
and IHC, but not supporting cells. Control (upper panel) shows strong staining of all OHC and IHC. One month after a moderate dose of carboplatin (50–75mg/kg,
i.p.) there are patches of stained IHC separated by large regions of missing IHC. OHC were present and appeared normal. (B) Photomicrographs of thin sections
stained with toluidine blue taken tangential to the habenula perforata. Dashed line (upper panel) showing the darkly stained nerve fibers in the openings in the
habenular perforata (HP) in the osseous spiral lamina (dashed line) of a normal control ear. Each habenular opening in control ears is filled with nerve fibers (upper
panel) whereas in carboplatin-treated ears (bottom panel), many nerve fibers are missing in the habenular openings. (C) Schematic of a cochleogram showing the
typical pattern of IHC loss induced by a moderate dose of carboplatin. In this depiction, roughly 40–50% of the IHC were missing along the length of the cochlea
whereas OHC were intact. The cochleogram shows the percentage of missing IHC and OHC as a function of percent distance from the apex of the cochlea; cochlear
position related to frequency on the upper x-axis. (D) Carboplatin induced a large and rapid loss of nerve fibers (NF) in the habenula perforata 24–72 h post-treatment.
Significant nerve fiber (NF) loss occurred 24 h post-treatment; IHC occurred several days later. (E) Photomicrographs illustrating the condition of the synaptic region at
the base of the IHC of a normal control (left) and a carboplatin-treated animal (right). At 24 h post-treatment, many large vacuoles (red arrows) were observed at the
afferent terminals of the carboplatin-treated chinchilla unlike the control. Swelling distorted the basal pole of the IHC in carboplatin treated (arrowhead) animal. (F)
Transmission electron micrograph show thick myelin sheath around a normal auditory nerve fiber (ANF). Carboplatin caused significant demyelination 24–72 h
post-treatment (red arrows). Data schematized from Hofstetter et al. (1997b), Ding et al. (1999, 2001), and Wang et al. (2003).
for example in patients with auditory neuropathy (Abdala et al.,
2000). Since moderate doses of carboplatin selectively damage
the IHC while ostensibly leaving the OHC intact, DPOAE might
be expected to be normal in ears with just IHC loss. To test
this hypothesis, DPOAE input/output functions were measured
in chinchillas before and after treatment with a moderate to
high dose of carboplatin (Trautwein et al., 1996; Wake et al.,
1996a; Hofstetter et al., 1997a). In some animals, carboplatin
treatment caused near complete loss of IHC along the entire
length of the cochlea, but failed to damage the OHC (Figure 2A).
In such cases, where nearly all the IHCweremissing but the OHC
were intact, the DPOAE input/output functions were completely
normal (Figure 2B; Hofstetter et al., 1997a). Thus, the presence
of normal DPOAE does not mean that the cochlea is structurally
intact.
MODERATE IHC LESION HAS LITTLE
EFFECT ON THRESHOLD
IHC make one-to-one synaptic contact with the type I auditory
nerve fibers, providing the only pathway through which acoustic
information is relayed to the central auditory system (Spoendlin
and Baumgartner, 1977). Therefore, massive loss of IHC would
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FIGURE 2 | (A) Schematic cochleogram showing a very large IHC lesion with
little OHC loss induced by a high dose of carboplatin. IHC lesion extends over
nearly the entire length of the cochlea. (B) Schematic DPOAE input/output
function before and after carboplatin treatment at f1 and f2 frequencies
corresponding to the shaded region in the cochleogram in (A). DPOAE
input/output function was normal several months post-carboplatin despite
massive IHC loss, but retention of most OHC. Data schematized from
Hofstetter et al. (1997a).
greatly reduce input to the central auditory system and should
drastically disrupt hearing. To determine how IHC loss affects
hearing thresholds, pure tone audiograms were measured in
chinchillas using an avoidance conditioning paradigm before
and 1–2 months after moderate to high doses of carboplatin
designed to induce a range of IHC lesions (Salvi et al., 1978;
Lobarinas et al., 2013). After completing the hearing tests,
the cochleae were harvested to determine the magnitude and
type of cochlear lesion. The schematic audiogram (Figure 3A)
and schematic cochleogram (Figure 3B) illustrate the results
obtained when carboplatin induced a moderate IHC lesion,
but no OHC damage. In these cases, thresholds in quiet were
surprisingly unaffected, increasing very little despite the fact that
40–60% of the IHC were missing (Lobarinas et al., 2013). To
understand the relationship between hearing loss and IHC loss,
the threshold shifts post-carboplatin were plotted as a function
of percent IHC loss as schematized in Figure 3C. Hearing
thresholds were largely unaffected by small IHC lesions (<35%).
Threshold shifts gradually increased with moderate IHC lesions
(40–75%), but then increased substantially once the IHC lesions
exceeded 80%. One interpretation of these results is that the
pure tone audiogram is very poor at detecting small to moderate
sized IHC lesions and that thresholds in quiet only begin to rise
after the vast majority of IHC have been destroyed. Apparently,
only a few IHC and type I neurons are needed to detect a
tone in a quiet environment. The important implication of the
above results is that DPOAE and pure tone audiograms, two of
the most commonly used techniques for assessing hearing, are
insensitive to profound IHC/type I neuron damage. This suggests
additional measures are likely necessary to fully assess auditory
function.
IHC LESIONS HAVE LITTLE EFFECT ON
THE COCHLEAR MICROPHONIC
ECochG recorded from the ear canal, round window or within
the cochlea, provides researchers and clinicians with a powerful
tool to assess the functional integrity of the sensory and neural
structures in the cochlea. The cochlear microphonic (CM), an
AC receptor potential that mirrors the waveform of the acoustic
stimulus, is predominantly generated by the OHC with only
a small contribution from IHC (Dallos et al., 1972). Given
that carboplatin preferentially damages the IHC and does not
alter DPOAE, one would predict that the CM amplitude would
be largely unaffected by carboplatin treatments that primarily
target the IHC. Indeed, when the CM was recorded from the
round window of carboplatin treated chinchillas with large IHC
lesions but near complete retention of OHC, CM input/output
functions were nearly identical to control as schematized in
Figure 4A (Trautwein et al., 1996; Wang et al., 1997). These
results indicate that the IHC contribute little to the generation
of the CM and that the CM cannot be used to assess IHC
function.
IHC LESION SUPPRESSES THE
SUMMATING POTENTIAL
The summating potential (SP), reflected as a sound-evoked
DC shift near stimulus onset, is thought to be generated
predominantly by the IHC receptor potential with a much
smaller contribution from OHC (Russell and Sellick, 1983;
Zheng et al., 1997). Given that carboplatin preferentially damages
the IHC, one would predict that SP amplitude would be
greatly reduced in animals with large carboplatin-induced IHC
lesions. To test this hypothesis, the SP evoked by tone bursts
was recorded from the round window of carboplatin treated
chinchillas. In animals with large IHC lesions and complete
retention of OHC, SP amplitude was greatly reduced (∼60%)
compared to controls as schematized by the SP input/output
function in Figure 4B (Durrant et al., 1998). Destruction of both
IHC plus OHC resulted in a further decline in SP amplitude.
These results provide further confirmation that the SP is
generated presynaptically primarily by IHC and this component
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FIGURE 3 | (A) Schematic of pure tone audiogram obtained pre- and post-carboplatin in a chinchilla with ∼50–60% IHC and an intact OHC population (B). The
post-carboplatin thresholds (green) were slightly increased from baseline (black). (B) Schematic of cochleogram showing 50–60% IHC and minimal OHC loss following
carboplatin treatment (audiometric profile for such lesions depicted in A). Percent distance from the apex of cochlea shown on x-axis; position in the cochlea related to
frequency on upper x-axis. (C) Schematic showing the approximate relationship between the threshold shift vs. the percent IHC loss induced by carboplatin.
Thresholds remained nearly normal up to about 60% IHC loss, but then increased steeply once the IHC lesion exceeds 80%. Data schematized from Lobarinas et al.
(2013).
FIGURE 4 | (A) Schematic showing the CM input/output functions in control (black) vs. carboplatin-treated (green) chinchillas with large IHC loss but intact OHC. IHC
loss had little effect on CM amplitude. (B) Schematic illustrating the SP input/output functions in control (black) vs. carboplatin-treated (green) chinchillas with large
IHC lesion with retention of OHC. IHC lesion caused a large reduction (∼60%) in SP amplitude. (C) Schematic showing the CAP input/output function in control (black)
and carboplatin-treated chinchillas with a large (∼90%, green) or moderate (∼50%, red) IHC lesion and intact OHC. IHC loss resulted in a large decrease in CAP
amplitude; the amplitude reduction was proportional to IHC loss. Black horizontal dashed line at 10 µV used to derive CAP threshold for control group (∼10dB SPL,
blue arrow) vs. groups with 50% IHC loss (∼20 dB SPL, red arrow) or 90% IHC loss (∼45 dB SPL, green arrow). Data schematized from Trautwein et al. (1996), Wang
et al. (1997), and Durrant et al. (1998).
of the ECochG can be used to assess the functional status of
IHC.
IHC LOSS DEPRESSES THE COMPOUND
ACTION POTENTIAL
The auditory nerve compound action potential (CAP), consisting
of two negative peaks (N1 and N2), is the most widely studied
component of ECochG. The CAP is most effectively elicited by
acoustic stimuli with rapid rise time and is thought to reflect
the synchronized onset response of type I auditory nerve fibers
(Dallos, 1973; Zheng et al., 1996). Since the amplitude of the
CAP is a postsynaptic response that depends on the release
of excitatory neurotransmitter from the IHC, damage to the
IHC would be predicted to greatly reduce the CAP. To test
this hypothesis, CAP input/output functions were recorded from
carboplatin-treated chinchillas with different degrees of IHC
damage (Trautwein et al., 1996; Wang et al., 1997). In cases
where most IHC were destroyed (80–90%) and most OHC were
present, the amplitude of the CAP was greatly reduced compared
to controls, whereas moderate (∼50%) IHC loss resulted in
a modest amplitude reduction as schematized by the CAP
input/output functions in Figure 4C. These results indicate that
the reduction in CAP amplitude is proportional to the degree of
IHC loss (Wang et al., 1997; Qiu et al., 2000). CAP thresholds can
be derived from the input/output functions using an amplitude
criterion of 10 µV. In the schematic (Figure 4C), CAP threshold
was ∼10 dB SPL in the control group (blue arrow) and ∼20 dB
SPL in the carboplatin group with 50% IHC (red arrow). These
results suggest that auditory nerve fiber thresholds are only
slightly increased despite the moderate to severe IHC lesion.
However, in cases where∼90% of the IHC were missing and very
few nerve fibers would be available to generate a synchronized
CAP response, the CAP threshold had increased to ∼45 dB SPL
(green arrow). These results suggest that the CAP amplitude and
CAP threshold have the greatest utility for detecting damage to
the IHC/type I auditory nerve fibers.
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ACOUSTICALLY RESPONSIVE AUDITORY
NERVE FIBERS HAVE LOW THRESHOLDS
AND ARE SHARPLY TUNED
High impedance microelectrodes can be used to record the all
or none spike discharges from single auditory nerve fibers as
they leave the cochlea and enter the cochlear nucleus. Since each
type I auditory nerve fiber contacts a single IHC, the neural
output of a fiber reflects the activity from a discrete region of
the basilar membrane. When tone bursts are used to measure
the response of a single auditory nerve fiber, one can map out
the frequency-intensity combinations that are just capable of
evoking a response, the so-called frequency-threshold tuning
curve (Salvi et al., 1982, 1983; Wang et al., 1997). Each tuning
curve is characterized by a low threshold, narrowly tuned tip
(Figure 5A). The frequency with the lowest threshold at the tip
is the characteristic frequency (CF). The tuning curves of high
CF and medium CF neurons are characterized by a steep high
frequency slope above CF. Thresholds below CF also rise steeply,
but gradually give rise to a high-threshold, broadly tuned tail. The
tuning curves of low-CF neurons are more symmetrical and lack
the broad low-frequency tail (Wang et al., 1997; Salvi et al., 1983,
1982).
Extensive damage to the IHC could conceivably affect the
mechanical properties of the basilar membrane and alter the
tuning and sensitivity of auditory nerve fibers. To evaluate
this possibility, recordings were made from carboplatin-treated
chinchillas with extensive IHC loss along the entire length of
the cochlea as well as some OHC loss in the base of the
cochlea as schematized in Figure 5B (Wang et al., 1997). When
a microelectrode was advanced through the auditory nerve
bundle, comparatively few acoustically responsive nerve fibers
were encountered during the penetration, presumably due to
the extensive loss of IHC and type I nerve fibers. However,
when an acoustically responsive nerve fiber was encountered,
CF-thresholds were low and tuning curve shapes were similar
to those from normal control ears (Figures 5C–E; Wang et al.,
1997). Thus, despite the massive IHC loss, the remaining IHC
and type I neurons had low thresholds and sharp tuning which
may explain why behavioral thresholds were relatively normal
notwithstanding the large IHC loss. Apparently, sounds can
be detected in quiet with only a weak signal from the few
remaining IHC and type I neurons. Despite normal thresholds
and tuning, spontaneous and suprathreshold responses from
intact auditory nerve fibers were decreased in carboplatin-treated
animals, indicative of subtle damage to surviving IHCs, and/or
type I neurons (Wang et al., 1997).
CENTRAL GAIN COMPENSATES FOR
AUDITORY DEPRIVATION
If 75% of the IHC and type I neurons were destroyed, the central
auditory pathway would receive only 25% of its normal input, a
condition that would lead to a severe case of auditory sensory
deprivation. A shout to a carboplatin-deafferented ear would
likely be perceived as muﬄed unless there was some form of
compensation to boost the weak neural signal. To determine how
the central auditory system deals with diminished neural input
from a carboplatin-damaged cochlea, recordings were made
from chronically implanted electrodes in the cochlea (CAP),
inferior colliculus (IC), and auditory cortex (ACx) of awake
chinchillas before and after carboplatin treatment (Qiu et al.,
2000). The schematics in the upper half of Figure 6 show the
local field potential (LFP) input/output functions for the CAP
(panel A), IC (panel C) and ACx (panel E) pre- and 5 weeks
post-carboplatin treatment. The results portrayed in the upper
half are representative data obtained from animals with mild
IHC lesions of 20–30%. To facilitate a comparison across animals
and conditions, the amplitudes are expressed as a percentage of
the pre-treatment amplitude at 100 dB SPL. Consequently, all
the pre-treatment values equal 100% at 100 dB SPL. In cases
where 20–30% of the IHC were destroyed, the CAP amplitudes
were smaller than normal. At 100 dB, the post-carboplatin CAP
was reduced ∼20% (80% of normal). Figure 6B is a schematic
that shows the percent change in CAP amplitude at 80 dB as a
function of percent IHC loss. CAP amplitude declines rapidly
with IHC loss and the response is almost completely abolished
with a loss of 90%. If the output of the auditory nerve was simply
relayed up the central auditory pathway, the responses in the IC
and ACx would mirror the CAP. Inspection of responses from
the IC shows that the post-carboplatin input/output function
is only slightly below the pre-treatment curve (Figure 6C; Qiu
et al., 2000). The schematic in Figure 6D shows the percent
change in IC amplitude at 80 dB vs. percent IHC loss. The
slope of the IC function is roughly half that of the CAP, i.e., IC
amplitude at 80 dB was only reduced ∼40% compared to ∼80%
for the CAP. Carboplatin produced the most striking changes in
the ACx where the post-exposure amplitudes were larger than
pre-treatment values as schematized in Figure 6E. This cortical
hyperactivity was dynamic, developing gradually over several
days to weeks (Qiu et al., 2000). When the percent change
in ACx amplitude at 80 dB is compared to percent IHC loss
(Figure 6F), post-carboplatin amplitudes were 20–30% larger
than normal (enhanced) with small to moderate IHC lesions and
remarkably, only slightly below normal with near complete IHC
lesions.
Taken together, these results indicate that the signal from the
cochlea is progressively amplified as it is relayed to the central
auditory pathway eventually leading to hyperactivity in the ACx.
These findings are consistent with recent reports showing central
gain enhancement with various forms of cochlear pathology;
however, an unusual feature of carboplatin is that hearing
thresholds are largely unaffected by the cochlea pathology (Salvi
et al., 1990, 2000b; Sun et al., 2009; Stolzberg et al., 2011;
Yuan et al., 2014; Brotherton et al., 2015; Chen et al., 2016).
Interestingly, similar perceptual and electrophysiological changes
were observed in a recent study examining ouabain treatment in
mice, which selectively destroys type-1 SGN (Chambers et al.,
2016). Animals with a unilateral lesion of >95% of afferent
nerve fibers maintained relatively normal sound detection,
likely due to a progressive recovery of sound-evoked activity
along the central auditory pathway. Like the above results
with carboplatin treatment (Figure 6), ouabain treatment greatly
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FIGURE 5 | (A) Schematic of a low, medium and high CF auditory nerve fiber frequency-threshold tuning curves. The neuron’s CF maps to the tonotopic map of the
cochlea (frequency-place map upper x-axis, B). (B) Schematic cochleogram showing the percentage of missing IHC and OHC in a chinchilla treated with a high dose
of carboplatin that destroyed approximately 80–98% of the IHC; damage was more severe in the basal half of the cochlea. Carboplatin also damaged OHC in the
base (60–100%). (C–E) Schematic of auditory nerve fiber tuning curves from carboplatin treated animals with CFs near 300Hz (C, blue), 1000Hz (D, red), and
3000Hz (E, green). Dotted lines relate each neuron’s CF to IHC damage on tonotopic map (upper x-axis, B). Data schematized from Wang et al. (1997).
diminished auditory nerve responses while neural response were
partially recovered in the IC and almost completely recovered,
and in some cases enhanced, at the level of the ACx. Thus,
cochlear damage appears to trigger a cascade of neuroplastic
changes in the central auditory pathway to compensate for
the reduced neural output from a damaged cochlea. Increasing
the amplitude of a weak signal would make it easier for
the ACx to detect sounds; this may explain why mild to
moderate IHC and/or SGN loss has so little effect on auditory
thresholds.
DECREASED INHIBITION IN THE
AUDITORY CORTEX
Mechanistically, the heightened level of sound-evoked activity
in the ACx of carboplatin-treated chinchillas could be due
to increased excitation and/or decreased inhibition (Milbrandt
et al., 2000; Suneja et al., 2000; Vale and Sanes, 2002; Sanes
and Kotak, 2011). Gamma aminobutyric acid (GABA), a potent
and ubiquitous inhibitory neurotransmitter, is heavily expressed
in the central auditory system and ACx (Hendry and Jones,
1991; Prieto et al., 1994; Ling et al., 2005; Sacco et al., 2009)
Neonatal sensorineural hearing loss reduces the number of
GABAa receptors in the plasma membrane of layer 2/3 neurons
in ACx (Sarro et al., 2008); this would decrease GABAa-mediated
inhibition and may contribute to the hyperactivity seen in
the ACx with cochlear hearing loss. To determine if the
sound-evoked hyperexcitability in ACx was due to reduced
GABAa-mediated inhibition, we measured LFPs in the ACx of
normal and carboplatin-treated chinchillas while manipulating
inhibitory tone (Salvi et al., 2000a, 2014). When bicuculline,
a potent GABAa antagonist was applied locally to the ACx, it
increased the firing rate, broadened the tuning and lowered the
threshold of many ACx neurons (Wang et al., 2000). Bicuculline
applied to the surface of the ACx of normal-hearing chinchillas
also dramatically increased the amplitude of the sound-evoked
LFP in the ACx as schematized in Figure 7A; the amplitude
enhancement was much greater for the negative peak than the
positive peak. Figure 7B is a schematic that shows the time
course and percent increase in the magnitude of the positive and
negative peaks of the LFP response after bicuculline was applied
to the ACx of a normal chinchilla. The maximum increase
occurred ∼5min after bicuculline was applied to the ACx and
the response gradually recovered toward baseline values over
the following 30min as bicuculline washed out. These results
indicate that under normal conditions, GABA strongly inhibits
sound-evoked responses in the ACx, but when GABAa receptors
are blocked with bicuculline sound-evoked activity increases
dramatically.
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FIGURE 6 | Schematics in upper half illustrate the input/output functions recorded from the (A) round window of the cochlea (compound action potential,
CAP), (C) inferior colliculus (IC) and (E) auditory cortex (ACx) before and after carboplatin treatment that induced 20–30% IHC loss. Amplitude of local field potentials
(LFPs) expressed as a percentage of the pre-treatment amplitude measured at 100dB SPL. All pre-treatment amplitudes equal 100% at 100dB before carboplatin
treatment. Schematics in lower half show the percent change in amplitude of the LFPs recorded at 80 dB SPL vs. percent IHC loss; plots show result for the cochlear
CAP (B), IC (D), and ACx (F). Values above the dashed horizontal line in panel F indicate that at 80 dB SPL LFPs in the ACx were larger than normal for small to
moderate size IHC lesion, but response were smaller than normal for IHC lesions >80%. Negative slopes indicate that LFP measured at 80 dB SPL decrease as IHC
lesions increase. The decrease in amplitude was greatest for the CAP and least for the ACx. Data schematized from Qiu (1998) and Qiu et al. (2000).
As noted above (Figure 6), sound-evoked responses in the
ACx greatly increase after carboplatin treatment, potentially
indicating that GABA mediated inhibition was already
diminished. To investigate this possibility, bicuculline was
applied to the ACx of chinchillas that had been treated with
a moderate dose of carboplatin. As schematized in Figure 7C,
bicuculline failed to increase the amplitude of the sound-evoked
LFP in the ACx; instead there was a slight reduction that
dissipated over time. Thus, carboplatin treatment appears to
occlude the effects of bicuculline on ACx responses. Failure
of bicuculline to increase sound-evoked activity could occur if
there was a significant decline in GABAa receptors in the ACx,
an interpretation consistent with previous findings in hearing
impaired animals (Sarro et al., 2008). An alternative possibility is
that less GABA is released from presynaptic neurons; however,
this view is not supported by results from hearing impaired
animals (Sarro et al., 2008). While altered inhibition has been
observed in both cortical and subcortical auditory structures
following noise-induced hearing loss (Milbrandt et al., 2000;
Dong et al., 2010; Wang et al., 2011; Yang et al., 2011), it remains
to be determined if changes to GABA-mediated inhibition
are involved in the partial recovery of IC responses following
carboplatin treatment.
CRITICAL BAND PERCEPTUAL DEFICITS
WITH IHC LOSS
Taken together, the above results suggest that only a fraction of
IHC and type 1 nerve fibers are required for normal hearing
thresholds in quiet (Figure 3) because activity from the few
remaining intact nerve fibers, which maintain low thresholds and
sharp tuning (Figure 5), is progressively amplified through the
central auditory system (Figure 6). However, listening with few
IHC and type I neurons might be extremely challenging in more
difficult listening environments. Each IHC is contacted by 10–20
type I nerve fibers resulting in considerable redundancy in the
information relayed by each IHC to the central auditory system.
Moderate IHC and type I neural loss would greatly reduce this
redundancy and information transfer to the auditory brain which
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FIGURE 7 | (A) Schematic of sound-evoked local field potentials (LFPs) from
the auditory cortex (ACx) before (pre, solid black line) and after applying
bicuculline (dashed red line) to the surface of the ACx of a normal control. Note
increase in positive and negative peaks in the ACx waveform; increase in
negative peak was larger than positive peak. (B) Percent change in positive
and negative peaks in the LFP after applying bicuculline to the ACx. Bicuculline
caused a large increase in positive and negative peaks. Largest increase
occurred approximately 5min post-treatment. Amplitudes gradually recovered
with bicuculline washout. (C) Percent change in LFP after applying bicuculline
to the ACx of chinchillas that had been treated with a moderate dose of
carboplatin 1–2 months earlier. Bicuculline failed to induce an increase in
cortical LFP, but instead induced a small decrease in the LFP which partially
recovered 30 min after applying bicuculline. Data schematized from Salvi et al.
(2000a, 2014).
could result in auditory processing deficits in conditions with
decreased signal to noise ratio, such as detecting sounds in noisy
environments. To test this hypothesis, chinchillas were trained to
detect a tone burst in broadband noise (BBN), a technique often
used to investigate the internal critical band filters (Scharf, 1961,
1970). Consistent with previous results, pure tone thresholds
measured in quiet were only slightly higher (3–5 dB) than
baseline after administering a dose of carboplatin that destroyed
∼60–70% of the IHC as schematized in Figures 8A,B (Lobarinas
et al., 2013, 2016). Pure tone thresholds were then measured
in BBN with an overall SPL of 50 dB and a spectrum level of
∼7 dB as schematized in Figure 8C. During baseline testing,
tone thresholds in BBN increased with frequency up to around
8 kHz and then plateaued similar to previous results (Seaton and
Trahiotis, 1975). After carboplatin treatment, tone thresholds in
BBN increased at all frequencies; the 6–11 dB increase in signal to
noise ratios was statistically significant (Lobarinas et al., 2016).
According to critical band theory, detection of the signal
depends on the power in the signal relative to the power passing
through the width of the critical band (Scharf, 1970). The
carboplatin-induced increase in critical band values could result
from a widening of the critical band. However, since sharp tuning
is maintained at the auditory nerve (Figure 5) and IC (Wake
et al., 1996b), the absence of band widening would not alter the
amount of noise passing through the critical band and therefore
not alter the signal to noise ratios. However, it is still possible
that broader neural tuning could emerge at the level of the ACx
due to loss of GABA-mediated inhibition (Wang et al., 2002).
Alternatively, the increase in signal to noise ratios (Figure 8C)
could result from an increase in central gain because the total
amount of noise passing through a filter is the product of the
bandwidth times the gain.
NARROW BAND NOISE MASKING WITH
IHC LOSS
Another approach used to assess the frequency selectivity of
the auditory system is to measure tone burst thresholds at
frequencies below, at and above the center frequency of a narrow
band noise (NBN); a plot of threshold vs. frequency in the
presence of the masker defines the NBN masking profile (Egan
and Hake, 1950). The solid line in Figure 8D is a schematic
showing a typical masking profile for a NBN (100Hz bandwidth)
centered at 4 kHz. The baseline NBNmasking profile in a normal
chinchilla is asymmetric. Masked thresholds are highest at the
frequency of the masker, but decrease rapidly for frequencies
below 4 kHz. In contrast, masked thresholds decline gradually
at frequencies above the 4 kHz masker resulting in considerable
upward spread of masking. To determine if the NBN masking
profile was altered by the loss of IHC, chinchillas were treated
with a moderate dose of carboplatin that destroyed 60–70% of
the IHC (Figure 8B), which had little effect on thresholds in
quiet (Figure 8A). Following carboplatin-treatment, threshold at
the 4 kHz NBN masker increased approximately 10 dB, a result
consistent with the BBN masking pattern. A 10–12 dB threshold
increase also occurred at frequencies above the masker. Thus, the
tip and high-frequency leg of the NBN masking pattern were
shifted upward, but the bandwidth of the tip was essentially
unchanged indicating that frequency selectivity was normal near
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FIGURE 8 | (A) Schematic illustrating threshold in quiet before and after a moderate dose of carboplatin. (B) Schematic representing the IHC and OHC loss after a
moderate dose of carboplatin that induces a 60–70% IHC with little or no loss of OHC. (C) Schematic showing the threshold in 50 dB SPL broadband noise before
and after moderate dose of carboplatin. (D) Schematic illustrating the thresholds measured in narrowband noise (100 Hz bandwidth) centered at 4 kHz before and
after a moderate dose of carboplatin. Carboplatin-induced threshold elevations above 4 kHz reflect the upward spread of masking and those below 4 kHz reflect
remote masking. Data schematized from Lobarinas et al. (2016).
4 kHz. Paradoxically, masked thresholds were also elevated 10–
15 dB at frequencies (0.25–2 kHz) far below the 4 kHz masker, a
phenomenon known as remote masking. It has been suggested
that remote masking arises from OHC electromotility and
nonlinear motion of the basilar membrane because conditions
that disrupt the OHC reduce remote masking (Cervellera and
Quaranta, 1982; Salonna et al., 1992; Quaranta et al., 1999).
Since OHC appeared functionally intact, our results suggest that
IHC/type I neurons normally suppress remote masking as their
loss results in greater remote masking. Thresholds in NBN were
elevated over a broad range of frequencies, a pattern at odds
with basilar membrane mechanics. An alternative explanation
for the widespread increase in masked threshold is that it is
due to the loss of GABA-mediated inhibition in the ACx since
pharmacologic blockage of GABA-mediated inhibition results
in broadening of ACx tuning curves both above and below CF
(Wang et al., 2002).
SYNOPSIS
Much of the basic auditory research over the past century has
focused on the anatomy and physiology of the cochlea. As a
result, we now have noninvasive functional tests such as DPOAE
to evaluate the status of the OHC in the cochlea. DPOAE
are maintained at normal levels (Figure 2) if cochlear damage
is confined to IHC, but rapidly decline if the OHC are also
destroyed (Hofstetter et al., 1997a). The CM component of
ECochG can also be used to evaluate the functional status of
OHC as well. Selective destruction of the IHC with carboplatin
had no measureable effect on the CM (Figure 4A), consistent
with the notion that OHC are the dominant generators of this
potential. In addition, the SP of ECochG provides a powerful
tool for evaluating activity of IHC, since IHC loss results in a
massive decline, but not complete abolition, of this potential
(Figure 4B; Durrant et al., 1998). The CAP, the neural component
of ECochG, is useful for assessing the sensitivity and global neural
output of the cochlea. The decline in CAP amplitude is roughly
proportional to IHC loss (Figure 4C) whereas changes in CAP
threshold are more difficult to assess because a large decline in
CAP amplitude can make it difficult to clearly identify the CAP.
One of the most remarkable psychoacoustic findings from
the series of carboplatin studies reviewed here was that hearing
thresholds in quiet were nearly normal despite the massive loss
of IHC and type I neurons. Our auditory nerve fiber recording
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(Figure 5) and psychoacoustic (Figure 3) results suggest that
only a few normal functioning IHC and type I neurons are
needed to hear a tone in a quiet environment. How is it that we
can hear so well when only a few IHC and type I neurons are
connected to the brain? The answer to this question may relate
to the fact that we perceive sounds not just with the cochlea,
but also with our brain. The decrease in the neural output of
the cochlea likely triggers a series of homeostatic processes at
multiple stages of the auditory pathway that amplify these weak
signals so that by the time it reaches the IC or ACx, sound-
evoked responses are normal or even supra normal (Figure 6;
Qiu et al., 2000; Jiang et al., 2016). The increases in gain seem to
be most pronounced with mild to moderate IHC lesions, where
the largest increase in ACx response occurred (Figures 6E,F).
Since carboplatin-induced damage results in relatively matched
bilateral lesions, it is possible that recovery from more severe
IHC loss may be observed if lesions were restricted to one ear, as
was found recently for a ouabain model of auditory neuropathy
(Chambers et al., 2016). However, the fact that extensive recovery
of sound encoding (and even over amplification as in the ACx)
is observed in carboplatin-treated animals with bilateral lesions
suggests that central gain enhancement is not limited to ear-
or input-specific competitive changes but can also arise from a
balanced loss of input to both ears. Our results suggest that, at
least for carboplatin-induced cochlear damage, enhanced central
gain and neural amplification is due in part to the loss of
GABA-mediated inhibition in the ACx. However, a plethora
of additional mechanisms operating at multiple levels of the
auditory system are likely to be involved as well (Suneja et al.,
2000; Chen et al., 2007; Peppi et al., 2012; Auerbach et al.,
2014).
There is currently tremendous scientific and clinical interest
in a form of hidden hearing loss termed synaptopathy that
affects the synaptic ribbon at the base of the IHC, glutamatergic
receptors located on type I auditory nerve terminals and
neurotrophin3 which provides trophic support for SGN
(Liberman et al., 2011; Kujawa and Liberman, 2015; Shaheen
et al., 2015; Viana et al., 2015; Shi et al., 2016a,b; Suzuki et al.,
2016). Identifying the unique perceptual deficits associated
with this condition will provide additional tools for identifying
individuals with normal clinical audiograms that nonetheless
have significant auditory processing disruptions. Although
the histopathologies associated with carboplatin damage
in the chinchilla are likely somewhat different than those
with pure synaptopathy, our psychophysical studies suggest
that a simple tone in BBN noise detection task, something
that can be accomplished with a clinical audiometer, may
be a sensitive method for identifying damage confined to
the IHC and/or SGN. Tests of remote masking might also
be useful since remote masking increased in chinchillas
with selective damage to IHC and type I neurons whereas
remote masking decreases with age-related hearing loss
and salicylate ototoxicity, conditions likely to involve OHC
pathology.
Why does loss of IHC/type I neurons result in difficulties
hearing in noise?While remaining auditory nerve fibersmaintain
normal tuning and thresholds following carboplatin treatment
(Figure 5), there is evidence for reduced spontaneous and
maximum driven firing rates, which could lead to coding
deficits in noisy conditions (Wang et al., 1997). A recent
study has demonstrated that auditory nerve fibers with low
spontaneous firing rates are preferentially damaged by noise
exposure that causes hidden hearing loss (Furman et al.,
2013). These nerve fibers are characterized by a relatively
large dynamic range and wide threshold distribution and are
therefore well-equipped for coding sounds in noisy backgrounds,
suggesting that selective loss of these nerve fibers could lead
to problems hearing in noisy environments. Interestingly,
carboplatin treatment results in a decrease in the median
spontaneous firing rate of auditory nerve fibers, shifting
the population in favor of lower spontaneous rates rather
than higher (Wang et al., 1997). This suggests that the
difficulties hearing in noise experienced by carboplatin-treated
chinchillas is not likely due to the loss of a specific class of
auditory neurons, contrary to what is seen with noise-induced
hidden hearing loss, but may be due in part to the reduced
maximum driven rates seen at high sound levels (Wang et al.,
1997).
Adding to the complexity of cochlear hearing loss is the
fact that the central auditory system attempts to compensate
for peripheral change by turning up its gain. While central
gain enhancement is able to restore normal hearing under quiet
conditions (Figure 3), it may not adequately compensate for
peripheral dysfunction in more difficult sound environments
(Figure 7) or in response to temporally complex stimuli
(Lobarinas, 2006; Chambers et al., 2016). This could be because
central gain enhancement is most prominent in higher auditory
areas that lack the temporal precision required to follow rapid
acoustic fluctuations that brainstem and peripheral auditory
centers are optimized for. Alternatively, it could be a byproduct
of the mechanisms by which gain enhancement is achieved.
For instance, while a loss of cortical inhibition may allow
for recovery of rate-intensity coding following hearing loss,
it could also result in temporal coding deficits that may
contribute to impaired speech perception and difficulties hearing
in noisy conditions (Wehr and Zador, 2003; Scholl and Wehr,
2008).
Central adaptation to hearing loss is also likely crucial in the
development of auditory perceptual disorders like tinnitus and
hyperacusis. From a clinical perspective, it would be difficult
to account for loudness recruitment or hyperacusis (loudness
intolerance) based on the neural responses seen in the damaged
cochlea (Figures 1A,B). The large gain enhancements seen in
the ACx seem particularly relevant to loudness hyperacusis. To
our knowledge, no one has tested for evidence of hyperacusis
in carbolpatin-treated chinchillas to determine if loudness
intolerance is related to carboplatin-induced hyperactivity.
However, we have found a striking correlation between salicylate-
induced hyperactivity in the central auditory system of rats with
behavioral evidence of loudness hyperacusis (Chen et al., 2014,
2015). While enhanced central gain can compensate for the
reduced neural output of the cochlea, toomuch gain at low sound
levels could contribute to tinnitus whereas excess gain at high
levels may give rise to loudness hyperacusis.
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